Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-06 · accession 0001649094-24-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-10 | 2024-06-06 | PCVX | Gilbert Halley E | Dir | A - Grant | $0.00 | +1,550 | 7,175 | +28% | $0 |
| D | 2024-06-10 | 2024-06-06 | PCVX | Gilbert Halley E | Dir | A - Grant | $0.00 | +7,250 | 7,250 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-06 | A | A | 1,550 | $0.00 | 7,175 | D | — | — | (F1) Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. |
| 2 | Derivative | Stock Option (right to buy) | 2024-06-06 | A | A | 7,250 | $0.00 | 7,250 | D | $72.51 · — to 2034-06-05 | 7,250 Common Stock | (F2) The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. |